341 related articles for article (PubMed ID: 11709455)
1. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
2. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
3. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
4. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
5. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
9. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens.
Jaskowski TD; Schroder C; Martins TB; Mouritsen L; Hill HR
J Clin Lab Anal; 1995; 9(3):166-72. PubMed ID: 7602423
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies.
Peene I; Van Ael W; Vandenbossche M; Vervaet T; Veys E; De Keyser F
Clin Rheumatol; 2000; 19(4):291-5. PubMed ID: 10941811
[TBL] [Abstract][Full Text] [Related]
12. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
13. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
Hoffman IE; Peene I; Veys EM; De Keyser F
Clin Chem; 2002 Dec; 48(12):2171-6. PubMed ID: 12446473
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
[TBL] [Abstract][Full Text] [Related]
16. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
Van Praet JT; Vander Cruyssen B; Bonroy C; Smith V; Delanghe J; De Keyser F
Clin Exp Rheumatol; 2009; 27(6):971-6. PubMed ID: 20149314
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
18. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
20. Detection of antinuclear antibodies (ANA), antibodies to double stranded DNA (anti-dsDNA) and antibodies to extractable nuclear antigens (anti-ENA) in Greek patients.
Stamouli M; Skliris A; Reppa D; Maganaki E; Totos G
Clin Lab; 2013; 59(3-4):283-91. PubMed ID: 23724616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
